Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda Brower

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Biotechnology Healthcare|February 9, 2013
Biotech-pharma partnerships reach all-time highAmanda Brower
Biotechnology Healthcare|February 2, 2013
Biotech capital markets finally open after long droughtAmanda Brower
Biotechnology Healthcare|January 16, 2013
Making a RHIOlistic Effort To Improve Quality of CareAmanda Brower
Biotechnology Healthcare|February 21, 2013
'Generic' biotech products: are the floodgates open? At whose expense?Amanda Brower
Biotechnology Healthcare|February 21, 2013
Big pharma moves into biologicsAmanda Brower
Biotechnology Healthcare|January 16, 2013
Debate on Follow-on Biologics Intensifies After Release of ReportAmanda Brower
Biotechnology Healthcare|April 6, 2012
Phase 4 research grows despite lack of FDA oversightAmanda Brower
Biotechnology Healthcare|April 6, 2012
Employers work to manage biologics in 2008 benefit designsAmanda Brower
Biotechnology Healthcare|April 6, 2012
Is there a better way to guide payers on off-label coverage?Amanda Brower
Biotechnology Healthcare|February 2, 2013
Payment issues stunt markets for Crohn's and psoriasis therapiesAmanda Brower
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Biotechnology Healthcare|February 9, 2013
Biotech-pharma partnerships reach all-time highAmanda Brower
Biotechnology Healthcare|February 2, 2013
Biotech capital markets finally open after long droughtAmanda Brower
Biotechnology Healthcare|January 16, 2013
Making a RHIOlistic Effort To Improve Quality of CareAmanda Brower
Biotechnology Healthcare|February 21, 2013
'Generic' biotech products: are the floodgates open? At whose expense?Amanda Brower
Biotechnology Healthcare|February 21, 2013
Big pharma moves into biologicsAmanda Brower
Biotechnology Healthcare|January 16, 2013
Debate on Follow-on Biologics Intensifies After Release of ReportAmanda Brower
Biotechnology Healthcare|April 6, 2012
Phase 4 research grows despite lack of FDA oversightAmanda Brower
Biotechnology Healthcare|April 6, 2012
Employers work to manage biologics in 2008 benefit designsAmanda Brower
Biotechnology Healthcare|April 6, 2012
Is there a better way to guide payers on off-label coverage?Amanda Brower
Biotechnology Healthcare|February 2, 2013
Payment issues stunt markets for Crohn's and psoriasis therapiesAmanda Brower
Pageof 5